Stockreport
UPDATE 1-Akorn settles U.S. SEC claims stemming from financial restatement [Reuters]
US:NASDAQ Investor Relations: investors.akorn.com
PDF
UPDATE 1-Akorn settles U.S. SEC claims stemming from financial restatement | Reuters Reuters Staff 2 Min Read (Adds details on settlement) March 26 (Reuters) - Akorn Inc and two former executives have agreed to settle claims stemming from inaccurate financial statements the generic drugmaker issued in 2014 that it later needed to restate, the U.S. Securities and Exchange Commission on Monday said. Akorn, former Chief Financial Officer Timothy Dick and former Controller David Hebeda agreed to settle a lawsuit filed in federal court in Chicago. Dick and Hebeda each agreed to pay a $20,000 penalty, the SEC said. Akorn will not have to pay any money as part of the settlement. It instead consented to a court order being entered enjoining it from future financial reporting and internal accounting control violations of the Securities Exchange Act. The Lake Forest, Illinois-based company and two former executives agreed to settle the case without admitting or denying wrongdoing. Akorn and law
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | AKRX | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
AKRX alerts
AKRX alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
AKRX alerts
High impacting AKORN news events
Weekly update
A roundup of the hottest topics
AKRX
NEWS
NEWS
- Akorn, Inc. (NASDAQ: AKRX) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating.[MarketBeat]
- Akorn, Inc. (NASDAQ: AKRX) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating.[MarketBeat]
- Akorn, Inc. (NASDAQ: AKRX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $16.00 price target on the stock.[MarketBeat]
- Akorn, Inc. (NASDAQ: AKRX) had its "buy" rating re-affirmed by analysts at Deutsche Bank AG.[MarketBeat]
- Fed. Circuit upholds decision canceling claims in Durezol eyedrops patent [Reuters][Reuters]
- More
AKRX
SEC Filings
SEC Filings
- 9/7/18 - Form 4
- 9/7/18 - Form 4
- 8/1/18 - Form 8-K
- AKRX's page on the SEC website
- More